Fig. 1 · Structure
Documents & Downloads
2′-Bromo-2′-deoxyuridine
Purine Nucleoside Analog
2′-Bromo-2′-deoxyuridine is a purine nucleoside analog that exhibits significant antitumor activity against indolent lymphoid malignancies. Its primary mechanisms of action include the inhibition of DNA synthesis and the induction of apoptosis in cancer cells. This compound is commonly utilized in research aimed at understanding cancer biology and developing therapeutic strategies for lymphoid cancers.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 4753-02-0 |
| Applications | Purine Nucleoside Analog |
| Formula | C9H11BrN2O5 |
| Molecular Weight | 307.10 |
| Synonyms | 2'-Bromo-2'-deoxy-D-uridine |
| SMILES | OC[C@@H]1[C@@H](O)[C@@H](Br)[C@H](N2C(NC(C=C2)=O)=O)O1 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.